Certara, Inc. Common Stock CERT
$8.00
-1.84%
at last close
Market Cap$1.22 billion
P/E Ratio—
Div Yield—
Volume1.43M
52-Week Range
$4.45$13.88
Analyst Ratings
- Consensus
- Hold — 3 Buy · 5 Hold · 0 Sell (8 analysts)
- Avg. Price Target
- $8.44 (+5.5% upside)
Key Stats
- Today's Range
- $7.95 – $8.29
- 50-Day Range
- $4.96 – $8.39
- 52-Week Range
- $4.45 – $13.88
- Volume
- 1.43 million shs
- Average Volume
- 3.90 million shs
- Market Cap
- $1.22 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 1.26
- Price / Sales
- 3.08
Short Interest
- Short Interest
- 0.72%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $395.63 million
- Net Income
- $-68,403,000
- Net Margin
- -17.29%
- Return on Equity
- -7.08%
- Debt-to-Equity
- 0.30
About Certara, Inc. Common Stock
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
Related Stocks
Compare head-to-head: CERT vs MSFT·CERT vs ORCL·CERT vs PLTR·CERT vs SHOP
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.